THEBalanced Truth

News should be accessible, free and fair.

← All headlines

Health

HHS to Allow Wider Access to Unapproved Peptide Injections

Left 8Center 3Right 2

What's new

New reports indicate the policy is still a draft that will be open for public comment for two weeks before being finalized.

This story is developing. The page was updated October 29, 2026 at 8:26 PM CDT as new reports came in.

What everyone agrees on

  • Health and Human Services Secretary Robert F. Kennedy Jr. will allow broader access to certain unapproved peptide injections.
  • The peptides have not been approved by the FDA.
  • Compounding pharmacies will be permitted to make and sell these peptides.

Each fact above was reported by outlets on the left, center and right.

How each side framed it

Left-leaning outlets · 8

Left-leaning outlets emphasized that the decision was made unilaterally by Kennedy, noted that FDA scientists had opposed it, and questioned whether the move would be enough to meet demand.

Center-leaning outlets · 3

Center-leaning outlets focused on the regulatory process, describing the move as bypassing FDA rules and linking it to the 'Make America Healthy Again' agenda, while noting the policy remains under review.

Right-leaning outlets · 2

Right-leaning outlets highlighted Kennedy's role in removing restrictions on the peptides and noted that the measure would be open for public comment for two weeks before being finalized, despite FDA opposition.

Still disputed

  • Left and right outlets report that FDA scientists opposed the move, while center outlets do not mention this opposition.
  • Some reports describe the policy as temporary or still subject to a public comment period before finalization, while others describe it as taking effect immediately.

Read the original reporting

See a mistake?

A simple way to report a wrong or missing fact, with no sign-up, is coming soon. Every correction will be listed publicly.

This page was written by AI from each outlet's headline and short description, following our published rules. Always check the original reporting.